Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science (RC2 Clinical Trials Optional)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 10 Dec 2024
- Closes
- 28 Sept 2026, 23:59 UTC
- Reference
- PAR-25-156
- Location
- United States
- Sector
- Healthcare & Pharma
Details
The purpose of the High Impact Specialized Innovation Programs (SIPs) is to support the development and demonstration of unique hub capabilities, research platforms and/or resources to address in a timely manner critical gap areas and/or roadblocks in clinical and translational science at awarded UM1 Clinical and Translational Science Awards (CTSA) Program Hubs (PAR-24-272). Successful programs supported through this funding opportunity are expected to lay a strong foundation for future adoption and/or dissemination of capabilities to additional CTSA Program Hubs. Eligibility: Other Eligible Applicants include the following:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
CFDA number(s): 93.350
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Context for bidders
We hold 408 notices from National Institutes of Health, going back to May 2023 — 390 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 399 open Healthcare & Pharma tenders in United States. This one closes in 4 days.
More from this buyer
- Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)· closes 10 Nov
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)· closes 10 Nov
- NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed)· closes 17 Apr
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)· closes 10 Nov
- Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional)· closes 25 May
Similar Healthcare & Pharma tenders
- Breathing Apparatus — Safety and Rescue Equipment· closes 26 Oct
- Advancing bio-printing of living cells for regenerative medicine· closes 22 Sept
- Development of cell-free protein synthesis platforms for discovery and/or production of biologicals· closes 13 Apr
- Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential· closes 13 Apr
- Development of innovative antimicrobials against pathogens resistant to antimicrobials· closes 13 Apr
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- ФІЛІЯ «ЛОКОМОТИВНА КОМПАНІЯ» АКЦІОНЕРНОГО ТОВАРИСТВА «УКРАЇНСЬКА ЗАЛІЗНИЦЯ» invites bids for МилоФІЛІЯ «ЛОКОМОТИВНА КОМПАНІЯ» АКЦІОНЕРНОГО ТОВАРИСТВА «УКРАЇНСЬКА ЗАЛІЗНИЦЯ» · Ukraine
- Renovation of electrical services in Ward No 1 and main casualty area at Dr BSA Hospital Rohini DelhiPublic Works Department · CE/SE/B2-B24 · EE/B243(N) · India
- Repair work of road Patch by Hot Mix Plant From Chandan Medical Store to Transformer Ward63 Under Zone02Kanpur Municipal Corporation, Kanpur, UP · India
- Procurement of Cytotoxic Drugs used in Hormonal, Immuno, Supportive and ChemotherapyHEALTH · Mauritius
- Procurement of Cytotoxic Drugs Used in Targeted Therapy (Annual Requirements) Mhpq/Pharm/2026-2027/Q66 OIBHEALTH · Mauritius
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →